There were no differences in prefrontal-limbic TSPO availability between individuals in the PTSD group with or without comorbid MDD (p = 0.60) or current psychotropic medication use (p = 0.59), and between individuals in the control group with or without trauma exposure (p = 0.85). This evidence concerns the gene TSPO and major depressive disorder.